Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
Medindia
19h
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa
BE HEARD I and BE HEARD II are the first Phase 3 trials to evaluate the efficacy and safety of an IL-17A and IL–17F inhibitor, BIMZELX ® (bimekizumab-bkzx), in the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Votes to accept $2.8B plan
At least 100 killed in landslide
Arrested, charged w/ fraud
Will miss her ninth Olympics
Calls Trump claim dangerous
Harvard grads stage walkout
Mosby spared prison time
'Quid pro quo' probe
To address Congress soon
Dow drops 600+points
Werder leaving ESPN
To launch $5 value meal
Evans suffers minor stroke
Mortgage rates fall below 7%
Expects a 2024 cash burn
Wade launches Translatable
Bill to prevent CBDCs
Industry targeting youth
Mahomes, Reid back Butker
La. criminalizes abortion pills
Limits state-affiliated media
Opposes tariffs on CN EVs
Sued by cancer victims
Dow falls by over 600 points
Cavaliers fire Bickerstaff
Warns of salmonella outbreak
Holds rally in South Bronx
OH gov. calls special session
Planet parade 2024
WH state dinner for Kenya
HPV vaccine benefits for men
X to make 'likes' private
Feedback